These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612 [TBL] [Abstract][Full Text] [Related]
3. Improved health-related quality of life and functional status after surgical ventricular restoration. Sartipy U; Albåge A; Lindblom D Ann Thorac Surg; 2007 Apr; 83(4):1381-7. PubMed ID: 17383343 [TBL] [Abstract][Full Text] [Related]
4. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423 [TBL] [Abstract][Full Text] [Related]
5. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456 [TBL] [Abstract][Full Text] [Related]
6. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726 [TBL] [Abstract][Full Text] [Related]
8. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019 [TBL] [Abstract][Full Text] [Related]
9. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction. Giallauria F; Lucci R; De Lorenzo A; D'Agostino M; Del Forno D; Vigorito C Age Ageing; 2006 Nov; 35(6):601-7. PubMed ID: 16951263 [TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010 [TBL] [Abstract][Full Text] [Related]
11. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618 [TBL] [Abstract][Full Text] [Related]
12. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ; J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664 [TBL] [Abstract][Full Text] [Related]
13. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522 [TBL] [Abstract][Full Text] [Related]
14. Surgical restoration of the left ventricle for postinfarction aneurysm. Castiglioni A; Quarti A; Schreuder J; Blasio A; Benussi S; Torracca L; Maisano F; Alfieri O Ital Heart J; 2002 Jun; 3(6):370-4. PubMed ID: 12116802 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308 [TBL] [Abstract][Full Text] [Related]
16. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE; Lombraña A; Duarte P; Di Gennaro F J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147 [TBL] [Abstract][Full Text] [Related]
17. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932 [TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998 [TBL] [Abstract][Full Text] [Related]
20. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]